Medicine and Dentistry
Heart Failure
100%
Right Ventricle
86%
Great Arteries
86%
Persistent Truncus Arteriosus
43%
Ventricular Assist Device
43%
Heart Right Ventricle Function
43%
Systematic Review
43%
Combination Therapy
43%
Meta-Analysis
43%
Funnel Chest
43%
Myasthenia gravis
43%
Melanoma
43%
Severe Acute Respiratory Syndrome Coronavirus 2
43%
Immune Checkpoint Inhibitor
43%
Sensitization
21%
Human Leukocyte Antigen
21%
Heart Right Ventricle Failure
21%
Malignant Neoplasm
21%
Immune-Related Adverse Events
21%
Cardiac Dysrhythmia
17%
Ejection Fraction
17%
New York Heart Association Class
17%
COVID-19
14%
Heart Left Ventricle Ejection Fraction
13%
Titrimetry
13%
Clinical Study
8%
Right Ventricular Function
8%
Hazard Ratio
8%
All Cause Mortality
8%
Chemotherapy Agent
7%
mRNA Vaccine
7%
Immune System
7%
Retrospective Study
7%
Pembrolizumab
7%
Cancer Therapy
7%
Autoimmunity
7%
Keyphrases
New-onset Heart Failure
43%
Meta-analysis
43%
Longitudinal Follow-up
43%
Systemic Right Ventricle
43%
Systematic Meta-analysis
43%
Right Ventricular Function
43%
Congenitally Corrected Transposition of the Great Arteries (ccTGA)
43%
Guideline-directed Medical Therapy
43%
Bioactive Adrenomedullin
43%
Heart Failure Hospitalization
33%
Standardized Mean Difference
17%
NYHA Class
17%
Right Ventricular Ejection Fraction
17%
Poor Outcome
17%
Arrhythmia
17%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
17%
Human Leukocyte Antigen Sensitization
14%
Bio-ADM
12%
Left Ventricular Ejection Fraction
10%
Up-titration
10%
Combined Endpoints
10%
Immune System Dysregulation
10%
Concurrent Vaccination
10%
BBIBP-CorV
10%
Sinopharm
10%
Effect Estimates
8%
Adulthood
8%
Increased Incidence
8%
Prognostic Evaluation
8%
Early Mortality
8%
Risk Ratio
8%
PubMed
8%
Selection Criteria
8%
Systematic Literature Review
8%
Embase
8%
Heart Failure
8%
Small Sample Size
8%
Mortality Rate
8%
Web of Science
8%
Left Ventricular Function
8%
Plasma Concentration
8%
Scopus
8%
Confidence Interval
7%
Hazard Ratio
7%
All-cause Mortality
7%
High Risk
7%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
86%
Combination Therapy
43%
Disease Exacerbation
43%
Adrenomedullin
43%
Immune Checkpoint Inhibitor
43%
Melanoma
43%
SARS Coronavirus
43%
Myasthenia gravis
43%
Congestive Heart Failure
37%
Malignant Neoplasm
28%
Heart Arrhythmia
21%
Adverse Event
21%
All Cause Mortality
17%
Coronavirinae
14%
Diseases
14%
Clinical Study
10%
mRNA Vaccine
7%
Retrospective Study
7%
Pembrolizumab
7%
Chemotherapy Agent
7%
Immunoassay
6%
Brain Natriuretic Peptide
6%
Cardiovascular Disease
6%
Diuretic Agent
6%
Disease Course
5%
Atrial Fibrillation
5%
Prevalence
5%
